IDiyas

For the Inventor, By the Inventor

Somerville, NJ, United States of America

Thomas A Rano

USPTO Granted Patents = 12

Average Co-Inventor Count = 3.5

ph-index = 4

Forward Citations = 77(Granted Patents)


Location History:

  • Sommerville, NJ (US) (1992)
  • Somerville, NJ (US) (1992 - 2003)

Company Filing History:

goldMedal12 out of 4,770 
 
Merck + Co., Inc.
 patents

Years Active: 1992-2003

Loading Chart...
12 patents (USPTO):
1. 6642237 - Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides and uses thereof (2003-11-04),
2. 6589962 - Alpha-hydroxy-gamma-[[(carbocyclic-or heterocyclic-substituted)amino]carbonyl]alkanamide derivatives and uses thereof (2003-07-08),
3. 5336674 - 2-phenanthridinyl carbaphenem antibacterial agent (1994-08-09),
4. 5328904 - 2-phenanthridinyl carbapenem antibacterial agents (1994-07-12),
5. 5216146 - 2-benzocoumarinyl-carbapenems (1993-06-01),
6. 5214139 - 2-phenanthridonyl-carbapenems (1993-05-25),
7. 5208328 - 2-phenanthridonyl carbapenem intermediates (1993-05-04),
8. 5182384 - 2-benzocoumarinyl carbapenems (1993-01-26),
9. 5162314 - 2-benzocoumarinyl carbapenems (1992-11-10),
10. 5157033 - 2-phenanthridonyl carbapenems having cationizeable substituents (1992-10-20),
11. 5153186 - 2-benzocoumarinyl-carbapenems (1992-10-06),
12. 5153185 - 2-phenanthridonyl carbapenems (1992-10-06),

Sure. Here is the article about inventor Thomas A Rano:

Title: Thomas A Rano - The Innovative Mind Behind HIV Protease Inhibitors

Introduction:

Thomas A Rano, a prominent inventor based in Somerville, NJ, has made significant contributions to the field of medicine with his groundbreaking innovations in HIV protease inhibitors. With an impressive portfolio of 12 patents, Rano is recognized for his valuable work in the prevention and treatment of HIV and AIDS.

Latest Patents:

Rano's latest patents include Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides and Alpha-hydroxy-gamma-[(carbocyclic-or heterocyclic-substituted)amino]carbonyl]-alkanamide derivatives. These compounds serve as inhibitors of HIV protease and replication, offering promising solutions for combating HIV viral mutants resistant to current treatments.

Career Highlights:

Currently employed at Merck & Company, Inc., Thomas A Rano has excelled in his role, spearheading research and development efforts in the pharmaceutical industry. His innovative approaches have led to the creation of novel treatments for HIV and AIDS, showcasing his expertise in drug discovery and development.

Collaborations:

Throughout his career, Rano has collaborated closely with esteemed colleagues such as Frank P DiNinno and Mark L Greenlee. Together, they have synergized their skills and knowledge to push the boundaries of medical science, paving the way for advanced therapies in the fight against HIV/AIDS.

Conclusion:

In conclusion, Thomas A Rano stands as a visionary inventor whose contributions have revolutionized the treatment landscape for HIV and AIDS. His dedication to research and innovation underscores his commitment to improving global healthcare and addressing critical medical needs. Rano's patents serve as a testament to his ingenuity and unwavering pursuit of excellence in the field of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…